Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Accumulated Expenses: 2021-2024

Historic Accumulated Expenses for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $15.9 million.

  • Prime Medicine's Accumulated Expenses fell 41.13% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 41.13%. This contributed to the annual value of $15.9 million for FY2024, which is 12.71% up from last year.
  • Latest data reveals that Prime Medicine reported Accumulated Expenses of $15.9 million as of FY2024, which was up 12.71% from $14.1 million recorded in FY2023.
  • Over the past 5 years, Prime Medicine's Accumulated Expenses peaked at $37.2 million during FY2021, and registered a low of $10.7 million during FY2022.
  • Over the past 3 years, Prime Medicine's median Accumulated Expenses value was $14.1 million (recorded in 2023), while the average stood at $13.6 million.
  • In the last 5 years, Prime Medicine's Accumulated Expenses plummeted by 71.26% in 2022 and then spiked by 32.02% in 2023.
  • Prime Medicine's Accumulated Expenses (Yearly) stood at $37.2 million in 2021, then tumbled by 71.26% to $10.7 million in 2022, then spiked by 32.02% to $14.1 million in 2023, then increased by 12.71% to $15.9 million in 2024.